Skip to main content

Company News

  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
    Read more

  • April 20, 2023

    bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

    bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.
    Read more

  • February 21, 2023

    bioMérieux launches a PCR kit for detection of the monkeypox virus

    bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.
    Read more

  • January 18, 2023

    bioMérieux and InDevR partnership

    bioMérieux is making a $5 million investment in InDevR, and will be the exclusive distributor in Europe of VaxArray®, a state-of-the-art vaccine quality control platform developed by the American company.
    Read more

Follow us on Socials for more news!